European Journal of Cancer Supplements, 1359-6349

Tidskrift

Fler filtreringsmöjligheter
  1. 2010
  2. Systematic functional analysis of microRNAs by transfection of 1129 miRNAs into prostate cancer cells

    R. Bjerkvig, S. K. Leivonen, P. Ostling, A. Aakula, P. Kohonen, R. Makela, Zandra Hagman, H. Edgren, Yvonne Ceder, M. Perala & O. Kallioniemi, 2010, I : EJC Supplements. 8, 7, s. 177-177

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  3. Validation study of the prognostic significance of beta-microseminoprotein and cysteine-rich secretory protein-3 after radical prostatectomy using automated image analysis

    Anna K Dahlman, E. Rexhepaj, D. Brennan, W. Gallagher, T. Schlomm, Karin Jirström & Anders Bjartell, 2010, I : EJC Supplements. 8, 5, s. 136

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  4. 2009
  5. EUROCOURSE: towards optimisation of the use of cancer registries for scientific excellence in cancer research in Europe: an FP7 ERA-net project

    J. Coebergh, C. J. G. van den Hurk, H. H. Storm, R. Zanetti, H. Comber, A. Antilla, Joakim Dillner, F. Bray, S. Siesling & E. Steliarova-Foucher, 2009, I : EJC Supplements. 7, 2, s. 201-202

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  6. Feelings of loss and shame after having lost a testicle: a population-based long-term follow-up of testicular-cancer survivors

    J. S. Skoogh, G. S. Steineck, Eva Cavallin-Ståhl, U. O. UIrica Olofsson, M. L. Magnus Lindwall, Ulf Håkansson, B. J. Boo Johansson & U. S. Ulrika Stierner, 2009, I : EJC Supplements. 7, 2, s. 445-445

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  7. Increased cardiovascular morbidity and mortality following endocrine treatment for prostate cancer: an analysis in 30,642 men in PCBaSe Sweden

    M. Van Hemelrijck, H. Garmo, Ola Bratt, A. Bill-Axelson, M. Lambe, P. Stattin, L. Holmberg & J. Adolfsson, 2009, I : EJC Supplements. 7, 3, s. 1-1

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  8. Interim analysis of epidermal-growth factor receptor (EGFR) expression in a single-arm, phase II, first-line study (20060314) of panitumumab with FOLFIRI in the management of metastatic colorectal cancer (mCRC)

    C. Koehne, R. Hofheinz, L. Mineur, H. Letocha, R. Greil, J. Thaler, E. Gamelin, Eva Fernebro, L. Wright & M. Karthaus, 2009, I : EJC Supplements. 7, 2, s. 343-344

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  9. Organisational hazards when treating patients with cytotoxic drugs

    Sven Ternov, AnnSofie Fyhr & Roland Akselsson, 2009, I : EJC Supplements. 7, 2, s. 210-210

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  10. Pattern of use of second-line treatment for NSCLC in the Nordic countries

    A. Mellemgaard, Lars Ek, H. Riska & R. Tell, 2009, I : EJC Supplements. 7, 2, s. 527-527

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  11. 2008
  12. Anti proliferative activity on human colon cancer cells treated in vitro with extracts from Bolivian foods and other plants

    G. Rodrigo, G. Almanza, Rui-Dong Duan & Björn Åkesson, 2008, I : EJC Supplements. 6, 9, s. 198-198

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract